The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Famotidine (NDC 70771-1702). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
NDC 70771-1702-3
Famotidine Tablets USP, 20 mg
30 Tablets
Rx only
20 mg Label (2535d94c Fa5f 46c5 B57c 9a99c2426473 01)
NDC 70771-1703-3
Famotidine Tablets USP, 40 mg
30 Tablets
Rx only
40 mg Label (2535d94c Fa5f 46c5 B57c 9a99c2426473 02)
* Please review the disclaimer below.
